Novartis Bioventures Ltd Insider Trading $ALRN AILERON THERAPEUTICS INC
Get free email notifications about insider trading for Novartis Bioventures Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Novartis Bioventures Ltd. Novartis Bioventures Ltd is 10% Owner in Marina Biotech, Inc. ($MRNA) and 10% Owner in Altimmune, Inc. ($PIP) and 10% Owner in Tokai Pharmaceuticals Inc ($TKAI) and 10% Owner in AILERON THERAPEUTICS INC ($ALRN) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Akebia Therapeutics, Inc. ($AKBA) and in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in BICYCLE THERAPEUTICS plc ($BCYC).
Novartis Bioventures Ltd in AILERON THERAPEUTICS INC
Trading Symbol: ALRNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Novartis Bioventures Ltd: 10% Owner
Holdings: 2,100,004 shares
Latest Transaction: Apr 02 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Novartis Bioventures Ltd in AILERON THERAPEUTICS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATRX, AGLE, ARPO, ALRN, AKBA, ALT, BCYC, ELDN, GRTX, RARX, YMTX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 02 2019 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.90 | 20,610 | 39,159 | 2,079,394 | 2.1 M to 2.1 M (-0.98 %) |
Apr 02 2019 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.85 | 106,540 | 197,099 | 2,100,004 | 2.2 M to 2.1 M (-4.83 %) |
Mar 15 2019 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.92 | 43,800 | 84,096 | 2,206,544 | 2.3 M to 2.2 M (-1.95 %) |
Mar 15 2019 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.88 | 13,800 | 25,944 | 2,250,344 | 2.3 M to 2.3 M (-0.61 %) |
Mar 15 2019 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.12 | 132,738 | 281,405 | 2,264,144 | 2.4 M to 2.3 M (-5.54 %) |
Aug 22 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.30 | 20,388 | 46,892 | 2,396,882 | 2.4 M to 2.4 M (-0.84 %) |
Aug 20 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.10 | 8,700 | 18,270 | 2,417,270 | 2.4 M to 2.4 M (-0.36 %) |
Aug 20 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.10 | 8,808 | 18,497 | 2,425,970 | 2.4 M to 2.4 M (-0.36 %) |
Aug 16 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.15 | 2,635 | 5,665 | 2,434,778 | 2.4 M to 2.4 M (-0.11 %) |
Aug 16 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.26 | 3,300 | 7,458 | 2,437,413 | 2.4 M to 2.4 M (-0.14 %) |
Aug 14 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.36 | 1,600 | 3,776 | 2,440,713 | 2.4 M to 2.4 M (-0.07 %) |
Aug 14 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.44 | 5,615 | 13,701 | 2,442,313 | 2.4 M to 2.4 M (-0.23 %) |
Aug 10 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.48 | 235 | 583 | 2,447,928 | 2.4 M to 2.4 M (-0.01 %) |
Aug 10 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.78 | 1,000 | 2,780 | 2,448,163 | 2.4 M to 2.4 M (-0.04 %) |
Aug 08 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 2.97 | 1,739 | 5,165 | 2,449,163 | 2.5 M to 2.4 M (-0.07 %) |
Aug 08 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.02 | 2,942 | 8,885 | 2,450,902 | 2.5 M to 2.5 M (-0.12 %) |
Aug 06 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.33 | 4,702 | 15,658 | 2,453,844 | 2.5 M to 2.5 M (-0.19 %) |
Aug 02 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.22 | 8,181 | 26,343 | 2,458,546 | 2.5 M to 2.5 M (-0.33 %) |
Aug 02 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.07 | 4,500 | 13,815 | 2,466,727 | 2.5 M to 2.5 M (-0.18 %) |
Jul 31 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.27 | 2,000 | 6,540 | 2,471,227 | 2.5 M to 2.5 M (-0.08 %) |
Jul 31 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.38 | 6,458 | 21,828 | 2,473,227 | 2.5 M to 2.5 M (-0.26 %) |
Jul 27 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.63 | 7,937 | 28,811 | 2,479,685 | 2.5 M to 2.5 M (-0.32 %) |
Jul 27 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 3.84 | 12,460 | 47,846 | 2,487,622 | 2.5 M to 2.5 M (-0.50 %) |
Jul 25 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 4.11 | 700 | 2,877 | 2,500,082 | 2.5 M to 2.5 M (-0.03 %) |
Jul 25 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 4.25 | 30,600 | 130,050 | 2,500,782 | 2.5 M to 2.5 M (-1.21 %) |
Jul 18 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 4.71 | 12,500 | 58,875 | 2,531,382 | 2.5 M to 2.5 M (-0.49 %) |
Jul 18 2018 | ALRN | AILERON THERAPEUTI ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 5.15 | 300 | 1,545 | 2,543,882 | 2.5 M to 2.5 M (-0.01 %) |
Page: 1